alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › predict-conversion

predict-conversion

2 studies tagged predict-conversion, dated 2015-02-01 to 2023-02-09. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Plasma GFAP in Parkinson's disease with cognitive impairment and its potential to predict conversion to dementia 2023-02-09
  2. Role of cerebrospinal fluid biomarkers to predict conversion to dementia in patients with mild cognitive impairment: a clinical cohort study 2015-02-01

Studies

2 studies carry this tag.

Date range

2015 to 2023

Top journals

  • Clinical chemistry and laboratory medicine 1
  • NPJ Parkinson's disease 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Plasma GFAP in Parkinson's disease with cognitive impairment and its potential to predict conversion to dementia

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. NPJ Parkinson's disease 2023-02-09 Biomarkers

    Glial fibrillary acidic protein (GFAP) has been suggested as a biomarker for reactive astrogliosis.

  2. Role of cerebrospinal fluid biomarkers to predict conversion to dementia in patients with mild cognitive impairment: a clinical cohort study

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Clinical chemistry and laboratory medicine 2015-02-01 Biomarkers

    Our results confirm the key role of CSF biomarkers in predicting patient conversion from MCI to dementia.

All topic tags with their study counts